USING THE DIAGNOSTIC ASSESSMENT OF THE SEVERELY HANDICAPPED-II (DASH-II) TO MEASURE THE THERAPEUTIC EFFECTS OF RISPERIDONE
Tallennettuna:
VALDOVINOS, M.G., ET AL., USING THE DIAGNOSTIC ASSESSMENT OF THE SEVERELY HANDICAPPED-II (DASH-II) TO MEASURE THE THERAPEUTIC EFFECTS OF RISPERIDONE. JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, Vol. 48, no. 1 (2004), p. 53-59.
Ref.
129385
Sijainti:
SIIS R.104 Archivo
Palabras clave:
Discapacidad intelectual, Discapacidad severa, Efectos, Fármacos, Trastornos de la conducta, Tratamiento
Discapacidad intelectual, Discapacidad severa, Efectos, Fármacos, Trastornos de la conducta, Tratamiento
Samankaltaisia teoksia: USING THE DIAGNOSTIC ASSESSMENT OF THE SEVERELY HANDICAPPED-II (DASH-II) TO MEASURE THE THERAPEUTIC EFFECTS OF RISPERIDONE
- CHARACTERISTICS OF DEPRESSION AS ASSESSED BY THE DIAGNOSTIC ASSESSMENT FOR THE SEVERELY HANDICAPPED-II (DASH-II)
- VALIDITY OF THE MANIA SUBSCALE OF THE DIAGNOSTIC ASSESSMENT FOR THE SEVERELY HANDICAPPED-II (DASH-II)
- Validity and reliability of the Spanish version of the diagnostic assessment for the severely handicapped (DASH-II)
- CHARACTERISTICS OF AUTISM AS ASSESSED BY THE DIAGNOSTIC ASSESSMENT FOR THE SEVERELY HANDICAPPED - II (DASH-II)
- VALIDITY OF THE SLEEP SUBSCALE OF THE DIAGNOSTIC ASSESSMENT FOR THE SEVERELY HANDICAPPED-II (DASH-II)
- A COMPARISON OF THE DIAGNOSTIC ASSESSMENT FOR THE SEVERELY HANDICAPPED-II (DASH-II) AND THE ABERRANT BEHAVIOR CHECKLIST (ABC)